212 related articles for article (PubMed ID: 12626569)
1. Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.
Györy I; Fejér G; Ghosh N; Seto E; Wright KL
J Immunol; 2003 Mar; 170(6):3125-33. PubMed ID: 12626569
[TBL] [Abstract][Full Text] [Related]
2. Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.
Chen H; Gilbert CA; Hudson JA; Bolick SC; Wright KL; Piskurich JF
Mol Immunol; 2007 Feb; 44(6):1461-70. PubMed ID: 16765445
[TBL] [Abstract][Full Text] [Related]
3. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells.
Ghosh N; Gyory I; Wright G; Wood J; Wright KL
J Biol Chem; 2001 May; 276(18):15264-8. PubMed ID: 11279146
[TBL] [Abstract][Full Text] [Related]
4. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.
Ren B; Chee KJ; Kim TH; Maniatis T
Genes Dev; 1999 Jan; 13(1):125-37. PubMed ID: 9887105
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a novel repressor of beta-interferon gene expression.
Keller AD; Maniatis T
Genes Dev; 1991 May; 5(5):868-79. PubMed ID: 1851123
[TBL] [Abstract][Full Text] [Related]
6. PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells.
Desai S; Bolick SC; Maurin M; Wright KL
J Immunol; 2009 Nov; 183(9):5778-87. PubMed ID: 19828640
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.
Yu J; Angelin-Duclos C; Greenwood J; Liao J; Calame K
Mol Cell Biol; 2000 Apr; 20(7):2592-603. PubMed ID: 10713181
[TBL] [Abstract][Full Text] [Related]
8. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression.
Huang S; Shao G; Liu L
J Biol Chem; 1998 Jun; 273(26):15933-9. PubMed ID: 9632640
[TBL] [Abstract][Full Text] [Related]
9. An expanding job description for Blimp-1/PRDM1.
Bikoff EK; Morgan MA; Robertson EJ
Curr Opin Genet Dev; 2009 Aug; 19(4):379-85. PubMed ID: 19592232
[TBL] [Abstract][Full Text] [Related]
10. Human BSAP and BLIMP1 conform an autoregulatory feedback loop.
Mora-López F; Reales E; Brieva JA; Campos-Caro A
Blood; 2007 Nov; 110(9):3150-7. PubMed ID: 17682124
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells.
Ochiai K; Katoh Y; Ikura T; Hoshikawa Y; Noda T; Karasuyama H; Tashiro S; Muto A; Igarashi K
J Biol Chem; 2006 Dec; 281(50):38226-34. PubMed ID: 17046816
[TBL] [Abstract][Full Text] [Related]
12. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
13. PRDM1/BLIMP-1 modulates IFN-gamma-dependent control of the MHC class I antigen-processing and peptide-loading pathway.
Doody GM; Stephenson S; McManamy C; Tooze RM
J Immunol; 2007 Dec; 179(11):7614-23. PubMed ID: 18025207
[TBL] [Abstract][Full Text] [Related]
14. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.
Lotz C; Mutallib SA; Oehlrich N; Liewer U; Ferreira EA; Moos M; Hundemer M; Schneider S; Strand S; Huber C; Goldschmidt H; Theobald M
J Immunol; 2005 Jul; 175(2):1301-9. PubMed ID: 16002735
[TBL] [Abstract][Full Text] [Related]
15. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3.
Tanaka H; Muto A; Shima H; Katoh Y; Sax N; Tajima S; Brydun A; Ikura T; Yoshizawa N; Masai H; Hoshikawa Y; Noda T; Nio M; Ochiai K; Igarashi K
J Biol Chem; 2016 Mar; 291(12):6316-30. PubMed ID: 26786103
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.
Tam W; Gomez M; Chadburn A; Lee JW; Chan WC; Knowles DM
Blood; 2006 May; 107(10):4090-100. PubMed ID: 16424392
[TBL] [Abstract][Full Text] [Related]
18. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding.
Keller AD; Maniatis T
Mol Cell Biol; 1992 May; 12(5):1940-9. PubMed ID: 1569931
[TBL] [Abstract][Full Text] [Related]
19. Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation.
Morgan MA; Magnusdottir E; Kuo TC; Tunyaplin C; Harper J; Arnold SJ; Calame K; Robertson EJ; Bikoff EK
Mol Cell Biol; 2009 Nov; 29(21):5813-27. PubMed ID: 19737919
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing regulates Prdm1/Blimp-1 DNA binding activities and corepressor interactions.
Morgan MA; Mould AW; Li L; Robertson EJ; Bikoff EK
Mol Cell Biol; 2012 Sep; 32(17):3403-13. PubMed ID: 22733990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
